<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04635644</url>
  </required_header>
  <id_info>
    <org_study_id>ABC-4-DE</org_study_id>
    <nct_id>NCT04635644</nct_id>
  </id_info>
  <brief_title>Ultrasound Guided ESP Block Versus Intrathecal Morphine for Postoperative Analgesia in Major HPB Surgery.</brief_title>
  <official_title>Ultrasound Guided Erector Spinae Block Versus Intrathecal Morphine for Postoperative Analgesia in Major Hepatopancreaticobiliary Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the efficacy of USG-guided bilateral Erector spinae plane block (ESPB) with&#xD;
      intrathecal morphine (ITM) for postoperative analgesia after major hepatopancreaticobiliary&#xD;
      surgery (HPB)&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 15, 2021</start_date>
  <completion_date type="Anticipated">December 15, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 15, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cumulative opioid consumption</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>Nalbuphine consumption in mg equivalent to morphine dose</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Nalbuphine consumption in mg</measure>
    <time_frame>at 8, 48, and 72 hours postoperatively.</time_frame>
    <description>equivalent to morphine dose</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analgesic drug consumption other than nalbuphine</measure>
    <time_frame>at 8, 24, 48, and 72 hours postoperatively.</time_frame>
    <description>consumption in mg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Numerical Rating Scale (NRS) at rest and when coughing</measure>
    <time_frame>at 1, 2, 4, 8, 12, 24, 48 and 72 hours postoperatively</time_frame>
    <description>NRS is an 11-point (0=no pain and 10=worst pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate</measure>
    <time_frame>Intraoperatively</time_frame>
    <description>Heart Rate in beats /min</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Arterial Pressure</measure>
    <time_frame>Intraoperatively</time_frame>
    <description>Mean Arterial Pressure in mmHg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Postoperative nausea &amp; vomiting (PONV)</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>Number of patients developing PONV</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Erector Spinae Plane Block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive Erector spinae plane block.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intrathecal morphine ITM</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive Intrathecal morphine.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Erector Spinae Plane Block</intervention_name>
    <description>Patients will be turned into the prone position. A high-frequency linear ultrasound probe will be placed in a longitudinal parasagittal orientation 2.5-3 cm lateral to the T8 spinous process. The erector spinae muscles will be identified superficial to the tip of the T8 transverse process. After local infiltration of the needle insertion site with 2-3 ml of 2% lidocaine, a 21G 10 cm needle will be inserted using an in-plane approach in a cranial to caudal direction to contact the T8 transverse process. The location of the needle tip will be confirmed by hydrodissection with 2 mL of lidocaine 2% and visualizing linear fluid spread lifting the erector spinae muscle off the bony shadow of the transverse process on ultrasonographic imaging. A volume of 20 mL of 0.25% Bupivacaine is injected will be injected at this point. The same procedure will be repeated for the opposite side.</description>
    <arm_group_label>Erector Spinae Plane Block</arm_group_label>
    <other_name>ESP block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intrathecal morphine</intervention_name>
    <description>Patients will be placed on their right side. An intrathecal injection of morphine 200 Î¼g (0.2 mL of morphine sulfate 1 mg/mL) diluted in 1.8 mL normal saline will be administered at the L3-L4 or L4-L5 level with a 25 G Whitacre spinal needle.</description>
    <arm_group_label>Intrathecal morphine ITM</arm_group_label>
    <other_name>ITM</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age between 18 and 65 years with a body mass index (BMI) of 18-35 kg/m2,&#xD;
&#xD;
          -  patients with the American Society of Anesthesiologists (ASA) physical status I - II,&#xD;
&#xD;
          -  Patients scheduled for elective major hepatopancreaticobiliary surgery for benign or&#xD;
             malignant disease; major surgery is defined as an operation of anticipated duration of&#xD;
             more than one hour.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient's refusal&#xD;
&#xD;
          -  Allergy or contraindications to the study drugs,&#xD;
&#xD;
          -  Infection at the site of injection,&#xD;
&#xD;
          -  Coagulopathy,&#xD;
&#xD;
          -  Psychiatric disorders&#xD;
&#xD;
          -  Severely co-morbid patients,&#xD;
&#xD;
          -  Chronic pain syndromes,&#xD;
&#xD;
          -  Prolonged opioid medication,&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Magdy M. Mahdy, Lecturer</last_name>
    <phone>01096502058</phone>
    <email>magdy.mahdy@aun.edu.eg</email>
  </overall_contact>
  <location>
    <facility>
      <name>Assiut University hospital</name>
      <address>
        <city>Assiut</city>
        <state>Asyut Governorate</state>
        <zip>11111</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Magdy M Mahdy, Lecturer</last_name>
      <phone>01096502058</phone>
      <email>magdy.mahdy@aun.edu.eg</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 14, 2020</study_first_submitted>
  <study_first_submitted_qc>November 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 19, 2020</study_first_posted>
  <last_update_submitted>November 15, 2021</last_update_submitted>
  <last_update_submitted_qc>November 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Magdy Mohammed Mahdy Sayed</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

